A group of MPs is advocating for broader access to the weight-loss injection Mounjaro through the NHS, criticizing the current plan to provide it to only 220,000 eligible patients by 2028 as insufficient. They highlight that this figure represents just 6% of those who qualify, leading many to seek private alternatives.
The MPs emphasize the need for a more efficient system to manage prescriptions and monitoring, suggesting that learning from private providers could help reduce costs. They also call for improved access to obesity treatment services and a crackdown on the black market for weight-loss drugs.